Preventative or therapeutic agent for fibrosis

摘要

Disclosed is a siRNA having a full length of 30 or fewer nucleotides and targeting a sequence comprising 17 to 23 consecutive bases selected from the group consisting of bases at positions 1285 to 1305, bases at position to 1398 to 1418 and bases at positions 1557 to 1579, of SEQ ID NO: 1; wherein the sequence identity is as disclosed in the specification. Also disclosed is the use of said siRNA for treating pulmonary fibrosis or lung cancer